Detalhe da pesquisa
1.
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.
Cell
; 158(4): 929-944, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25109877
2.
ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer.
Proc Natl Acad Sci U S A
; 120(52): e2313693120, 2023 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38117852
3.
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer.
Breast Cancer Res
; 25(1): 117, 2023 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794508
4.
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance.
Mol Cancer
; 22(1): 15, 2023 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681803
5.
Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial.
Breast Cancer Res Treat
; 199(2): 281-291, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029329
6.
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo.
Nature
; 543(7647): 714-718, 2017 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28329761
7.
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Lancet Oncol
; 23(1): 149-160, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902335
8.
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Lancet Oncol
; 22(4): 476-488, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721561
9.
Incorporation of Patient-Reported Outcomes Measurement Information System to assess quality of life among patients with breast cancer initiating care at an academic center.
Cancer
; 127(13): 2342-2349, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33957704
10.
Prediction and clinical utility of a contralateral breast cancer risk model.
Breast Cancer Res
; 21(1): 144, 2019 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31847907
11.
Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.
Ann Surg
; 270(2): 364-372, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29727326
12.
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
N Engl J Med
; 375(8): 717-29, 2016 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27557300
13.
Adaptive Randomization of Neratinib in Early Breast Cancer.
N Engl J Med
; 375(1): 11-22, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406346
14.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
N Engl J Med
; 375(1): 23-34, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406347
15.
Evaluation of National Comprehensive Cancer Network guideline-based Tool for Risk Assessment for breast and ovarian Cancer (N-TRAC): A patient-reported survey for genetic high-risk assessment for breast and ovarian cancers in women.
J Genet Couns
; 28(3): 507-515, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30663827
16.
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.
Genome Res
; 25(6): 814-24, 2015 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25963125
17.
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Hum Mol Genet
; 24(10): 2966-84, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25652398
18.
Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.
Hum Mol Genet
; 24(1): 285-98, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25168388
19.
A breast cancer gene signature for indolent disease.
Breast Cancer Res Treat
; 164(2): 461-466, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28451965
20.
Tamoxifen therapy benefit for patients with 70-gene signature high and low risk.
Breast Cancer Res Treat
; 166(2): 593-601, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28776283